DUXAP10 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, DUXAP10 was found to facilitate cell proliferation and inhibit the apoptosis of CML (Yao et al., 2018) K652 and KG-1 cells by inhibiting PTEN expression.